2016
DOI: 10.1016/j.jstrokecerebrovasdis.2016.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Follow-Up of Anterior Pituitary Deficiency after Aneurysmal Subarachnoid Hemorrhage: Prospective Cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(21 citation statements)
references
References 29 publications
0
21
0
Order By: Relevance
“…Conducted studies provide evidence for the prevalence of neuroendocrine dysfunction in SAH survivors, ranging from 0 to 55% [16]. A recently published study has shown that pituitary dysfunction as a late complication of SAH is present in 25% of patients [17]. Neuroendocrine disturbances may develop or improve in months, or even three years, after TBI and SAH.…”
Section: Introductionmentioning
confidence: 99%
“…Conducted studies provide evidence for the prevalence of neuroendocrine dysfunction in SAH survivors, ranging from 0 to 55% [16]. A recently published study has shown that pituitary dysfunction as a late complication of SAH is present in 25% of patients [17]. Neuroendocrine disturbances may develop or improve in months, or even three years, after TBI and SAH.…”
Section: Introductionmentioning
confidence: 99%
“…The pathogenesis of aSAH [ 10 , 15 18 ] can also include traumatic brain injuries, genetic predisposition, and autoimmunity and neuroinflammatory responses. Insufficiencies in all pituitary hormones following SAH have been reported to differ from none to 68% in previous studies [ 5 , 11 , 17 , 19 ]. Our results revealed increased prolactin levels beginning 12 h after SAH.…”
Section: Discussionmentioning
confidence: 91%
“…Recent studies have also suggested that hypothalamic-pituitary insufficiency is very common following aSAH [ 3 5 ]. Hyperprolactinemia (HPRL) is physiological condition that occurs after intercourse and stressful activity, and during lactation and pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…In 34-36, 39, 42, 43, 45, 46] with a total of 705 participants evaluated the prevalence of Gn de ciency that was 0.33 (95% CI, 0.21-0.44, I 2 = 93.4%, P value <0.001). About hyperprolactinemia, the prevalence was 0.12 (95% CI, 0.07-0.16, I 2 = 69.3%, P value = 0.001) calculated by 12 studies [14,19,21,29,34,35,39,42,43,45,46] with a total of 621 participants. As shown in Table 3, it can be seen that the 95% con dence intervals of the prevalence of GHD or Gn de ciency and the remaining ACTH de ciency or hyperprolactinemia have no overlap respectively, so the prevalences of GHD or Gn de ciency were signi cantly higher than that of ACTH de ciency and hyperprolactinemia.…”
Section: Global Analysis For Pdmentioning
confidence: 97%
“…The included studies were published from 2004 and 2022, and the number of patients ranged from 20 to 417 per study, with a total of 1848 individuals. According to the zoning of the WHO Regional O ce, a total of 21 of these studies have focused on EURO[8,10,13,14,19,[21][22][23][29][30][31][32][33][34][35][36][37][38][39][40][41], the remaining 3 on SEARO [42][43][44], 2 on PAHO [45,46], and 1 on WPRO [47]. Of these studies, 22 articles had prospective study designs, and 5 were cross-sectional studies.…”
Section: Study Characteristicsmentioning
confidence: 99%